STOCK TITAN
  1. Home
  2. Sec-filings
  3. STE
  4. [Form 4] STERIS plc Insider Trading Activity

STERIS plc (STE) director Pierre Boulud receives 1,025 Career RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Boulud Pierre reported acquisition or exercise transactions in this Form 4 filing.

STERIS plc reported that director Pierre Boulud received a grant of 1,025 Career Restricted Stock Units, each representing the right to receive one STERIS ordinary share. The units are fully vested immediately and will be settled in ordinary shares six months after the cessation of the Director's Board service, bringing his reported direct holdings in these units to 1,392.

Positive

  • None.

Negative

  • None.
Insider Boulud Pierre
Role Director
Type Security Shares Price Value
Grant/Award Career Restricted Stock Units F1, F2 1,025 $0.00 $0.00
Holdings After Transaction: Career Restricted Stock Units — 1,392 shares (Direct)
Footnotes (2)
  1. F1. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
  2. F2. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
Career Restricted Stock Units granted 1,025 units Grant of Career Restricted Stock Units to director Pierre Boulud on 2026-08-10
RSU holdings after transaction 1,392 units Total Career Restricted Stock Units reported as directly held after the grant
Transaction price per unit $0.0000 Reported price per Career Restricted Stock Unit for the grant
Underlying ordinary shares per RSU 1 share per unit Each Career Restricted Stock Unit represents one STERIS ordinary share
Settlement timing Six months after cessation of Board service Timing for settlement of RSUs into STERIS ordinary shares
Career Restricted Stock Units financial
"Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share"
fully vested financial
"These Career Restricted Stock Units are fully vested immediately."
settled in STERIS ordinary shares financial
"They will be settled in STERIS ordinary shares six months after the cessation"
cessation of the Director's Board service financial
"six months after the cessation of the Director's Board service."

FAQ

What insider transaction did STERIS plc (STE) report for Pierre Boulud?
STERIS plc reported that director Pierre Boulud received a grant of 1,025 Career Restricted Stock Units. These units are a form of equity compensation linked to future delivery of STERIS ordinary shares.

How many Career Restricted Stock Units does Pierre Boulud hold after this STE Form 4?
Following the reported grant, Pierre Boulud holds a total of 1,392 Career Restricted Stock Units. This reflects the newly granted 1,025 units added to his previously reported holdings.

When will Pierre Boulud’s Career Restricted Stock Units in STE be settled?
Each Career Restricted Stock Unit will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service, according to the footnote disclosure.

Are the STERIS (STE) Career Restricted Stock Units granted to Pierre Boulud vested?
Yes. The filing states that these Career Restricted Stock Units are fully vested immediately. Although vested, they are deferred and will be settled in shares six months after his Board service ends.

What does each Career Restricted Stock Unit represent for STERIS plc (STE)?
Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share. The shares will be delivered six months after the cessation of the Director's Board service as specified in the footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Boulud Pierre
(Last)(First)(Middle)
C/O 70 SIR JOHN ROGERSON'S QUAY
(Street)
DUBLIN 2D02 R296
(City)(State)(Zip)
IRELAND
(Country)		2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Career Restricted Stock Units(1)08/10/2026A1,025 (2) (2)Ordinary Shares1,025$01,392D
Explanation of Responses:
1. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
2. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
Remarks:
/s/ John P. Ubbing, Authorized Representative under Power of Attorney08/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR